Abstract |
Sarcoidosis is a systemic granulomatous disorder of unidentified etiology, with a heterogeneous clinical presentation. It is characterized by a reduced delayed-type hypersensitivity to tuberculin and common antigens. The balance between Th1, Th17 and Regulatory T(Treg) cells controls T-cell proliferation and activation.The Th17/Treg ratio in the peripheral blood and bronchoalveolar lavage fluidis increased in patients with active sarcoidosis. Amplified IL-17A expression in granulomas and the presence of IL-17A+, IL-17A+IL-4+ and IL-17A+IFN-γ+ memory T helper cells in the circulation and BAL indicate Th17 cell involvement in granuloma induction and/or maintenance in sarcoidosis. Sarcoidosis should therefore be considered as a Th1/Th17 multisystem disorder and anti-IL-17/Th17 approaches that control and reduce IL-17Amay be an option, therefore, for the treatment of sarcoidosis.Here we provide a short overview as to the role of Th17 cells as critical cells in the pathogenesis of sarcoidosis.
|
Authors | Esmaeil Mortaz, Fatemeh Rezayat, Davar Amani, Arda Kiani, Johan Garssen, Ian M Adcock, Aliakbar Velayati |
Journal | Iranian journal of allergy, asthma, and immunology
(Iran J Allergy Asthma Immunol)
Vol. 15
Issue 4
Pg. 334-339
(Aug 2016)
ISSN: 1735-1502 [Print] Iran |
PMID | 27921415
(Publication Type: Journal Article, Review)
|
Chemical References |
|
Topics |
- Animals
- Cytokines
(immunology)
- Humans
- Sarcoidosis
(immunology, pathology)
- T-Lymphocytes, Regulatory
(immunology, pathology)
- Th1 Cells
(immunology, pathology)
- Th17 Cells
(immunology, pathology)
|